Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3187872
Max Phase: Preclinical
Molecular Formula: C17H20N4O
Molecular Weight: 296.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3187872
Max Phase: Preclinical
Molecular Formula: C17H20N4O
Molecular Weight: 296.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1CCN(c2cc(NC(=O)c3ccccc3)ncn2)CC1
Standard InChI: InChI=1S/C17H20N4O/c1-13-7-9-21(10-8-13)16-11-15(18-12-19-16)20-17(22)14-5-3-2-4-6-14/h2-6,11-13H,7-10H2,1H3,(H,18,19,20,22)
Standard InChI Key: QUWAUKDDNKSIJN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 296.37 | Molecular Weight (Monoisotopic): 296.1637 | AlogP: 2.97 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.12 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.85 | CX Basic pKa: 3.57 | CX LogP: 3.58 | CX LogD: 3.58 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.95 | Np Likeness Score: -1.77 |
1. PubChem BioAssay data set, |
Source(1):